نتایج جستجو برای: acute promyelocytic leukemia

تعداد نتایج: 688410  

2012
Sachiko Sakamoto Naoki Oiso Masakatsu Emoto Shusuke Uchida Ayaka Hirao Yoichi Tatsumi Itaru Matsumura Akira Kawada

Patients with hematologic malignancies are immunosuppressive and may develop cutaneous or invasive infections as a primary sign of immune suppression. Acute promyelocytic leukemia (acute myeloid leukemia M3) is caused by translocation of reciprocal chromosomal rearrangement t(15;17), which produces an oncogenic protein. We herein describe a 71-year-old man having cellulitis with leukocytopenia ...

Journal: :avicenna journal of medical biotechnology 0

background: acute promyelocytic leukemia (apl) is a subclass of acute myeloid leukemia. the chromosomal aberration in 95% of apl cases is t(15; 17) (q22; q21), which prevents cell differentiation. characterization of the underlying molecular lesion is valuable in determining optimal treatment strategy. the goal of this study was to develop a new and powerful flow- fish technique to detect the l...

Journal: :Haematologica 2008
Carlos Santamaría María Carmen Chillón Ramón García-Sanz Ana Balanzategui María Eugenia Sarasquete Miguel Alcoceba Fernando Ramos Teresa Bernal José Antonio Queizán María Jesús Peñarrubia Pilar Giraldo Jesús F San Miguel Marcos Gonzalez

BACKGROUND The gene for preferentially expressed antigen of melanoma (PRAME) has been shown to be over-expressed in acute promyelocytic leukemia, but its actual incidence and clinical impact are still unknown. DESIGN AND METHODS We studied PRAME expression at diagnosis using real-time quantitative polymerase chain reaction in 125 patients with acute promyelocytic leukemia enrolled in the Span...

Journal: :Journal of Nepal Paediatric Society 2018

Journal: :Haematologica 2012
James Scott McClellan Holbrook E Kohrt Steven Coutre Jason R Gotlib Ravindra Majeti Ash A Alizadeh Bruno C Medeiros

Early mortality in acute promyelocytic leukemia has been reported to occur in less than 10% of patients treated in clinical trials. This study reports the incidence and clinical features of acute promyelocytic leukemia patients treated at Stanford Hospital, CA, USA since March 1997, focusing on early mortality. We show that the risk of early death in acute promyelocytic leukemia patients is hig...

2016
Abdulsamad Wafa Faten Moassass Thomas Liehr Ayman Al-Ablog Walid Al-Achkar

BACKGROUND Acute promyelocytic leukemia is characterized by a typical reciprocal translocation t(15;17)(q22;q21). Additional chromosomal abnormalities are reported in only 23-43 % of cases of acute promyelocytic leukemia. CASE PRESENTATION Here we report the case of a 46-year-old Syrian Alawis woman with acute promyelocytic leukemia with the typical t(15;17) translocation, but with a second c...

Journal: :Haematologica 2010
José Cervera Pau Montesinos Jesús M Hernández-Rivas María J Calasanz Anna Aventín María T Ferro Elisa Luño Javier Sánchez Edo Vellenga Chelo Rayón Gustavo Milone Javier de la Serna Concha Rivas José D González Mar Tormo Elena Amutio Marcos González Salut Brunet Bob Lowenberg Miguel A Sanz

BACKGROUND Acute promyelocytic leukemia is a subtype of acute myeloid leukemia characterized by the t(15;17). The incidence and prognostic significance of additional chromosomal abnormalities in acute promyelocytic leukemia is still a controversial matter. DESIGN AND METHODS Based on cytogenetic data available for 495 patients with acute promyelocytic leukemia enrolled in two consecutive PETH...

Journal: :Haematologica 2016
Karen Keeshan Pauline Vieugué Shahzya Chaudhury Loveena Rishi Coline Gaillard Lu Liang Elaine Garcia Takuro Nakamura Nader Omidvar Scott C Kogan

The PML/RARA fusion protein occurs as a result of the t(15;17) translocation in the acute promyelocytic leukemia subtype of human acute myeloid leukemia. Gain of chromosome 8 is the most common chromosomal gain in human acute myeloid leukemia, including acute promyelocytic leukemia. We previously demonstrated that gain of chromosome 8-containing MYC is of central importance in trisomy 8, but th...

2011
Seonghoon Choi Hyeong-Su Kim Chang-Soo Jung Seong-Woong Jung Yun-Ja Lee Jin-Kyeong Rheu Jung-Rae Jo Nam-Ho Lee

Treatment by All-trans retinoic acid (ATRA) followed by anthracycline-AraC chemotherapy has improved the outcome of acute promyelocytic leukemia. ATRA is usually well tolerated, but a few major side effects can be observed. Retinoic acid syndrome (RAS) often occurs during the induction chemotherapy of acute promyelocytic leukemia. A pericardial effusion is a common cardiac manifestation but myo...

Journal: :Blood 1981
T R Breitman S J Collins B R Keene

The recent finding that retinoic acid induces terminal granulocytic differentiation of the human promyelocytic leukemia cell line, HL-60, prompted an investigation of the sensitivity to this inducer of human myelocytic leukemia cells in primary suspension culture. Of the 21 leukemic specimens, only cells from the two patients with acute promyelocytic leukemia differentiated in response to retin...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید